Skip to main content

Coronavirus: Vaccination

Question for Department for Business, Energy and Industrial Strategy

UIN 77780, tabled on 21 July 2020

To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps he is taking to ensure that the UK deal to purchase 90 million potential covid-19 vaccine doses complements global efforts to co-ordinate vaccine supplies and ensure priority groups in every country are vaccinated first.

Answered on

1 September 2020

The UK is working closely with international partners to ensure that when a vaccine is available, it will be accessible to everyone who needs it as soon as possible.

The UK has committed alongside other countries to support equitable and affordable access to COVID-19 vaccines and treatments for example, committing up to £250 million of UK aid to the Coalition for Epidemic Preparedness Innovations (CEPI) for the development of coronavirus vaccines. The UK has already committed £48 million to the COVID-19 Global Vaccine Access Facility (COVAX) Advanced Market Commitment (AMC) which supports low and middle-income countries (LMICs) to access a successful vaccine.

The UK is also working closely with CEPI, GAVI (Vaccine Alliance) and the WHO to shape the emerging proposal for the self-financing arm of COVAX, which can support both domestic access and equitable access to LMICs.

We continue to work with our international partners to ensure that where countries have bilateral deals – including whether we be in the fortunate position where we have excess doses, these could be contributed to the COVAX facility.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.